Navigation Links
L'Oreal Paris Celebrates Ten Years of Hope and Healing
Date:9/11/2007

from the

worlds of beauty, fashion and entertainment to raise much-needed funds

for OCRF.

Bring hope to the thousands of women and their loved ones who have been affected by this devastating disease. Join L'Oreal Paris in the fight against ovarian cancer. Hope begins with you.

ABOUT THE OVARIAN CANCER RESEARCH FUND

The Ovarian Cancer Research Fund is the leading independent, non-profit organization in the United States dedicated to advancing research, raising awareness and finding a cure. Ovarian cancer takes the lives of over 15,000 women in the United States each year, with over 22,000 new cases being diagnosed annually. There is currently no method of early detection, leading to late diagnosis in 75 percent of all cases. OCRF is committed to funding the best and the brightest of scientific investigators whose work focuses on new tools for detection, prevention, and better treatment options. To date, the OCRF has funded 112 researchers at 41 leading cancer institutes nationwide.

Every day the Ovarian Cancer Research Fund makes a difference in the lives of thousands of women and their families. With each new grant awarded, new steps are being taken toward finding a cure. With their commitment comes hope to all. For more information, please visit http://www.ocrf.org.

ABOUT L'OREAL PARIS

L'Oreal Paris is dedicated to women around the world and the company has been inspired to give back and make a difference in their lives. In 1997, L'Oreal Paris made a long-term commitment to The Ovarian Cancer Research Fund (OCRF), which continues to build. To date, L'Oreal Paris has helped raise over $13 million dollars on behalf of OCRF with fundraising efforts such as the L'Oreal Legends Gala and L'Oreal's annual "Color of Hope" bracelet and cosmetic collection.

L'Oreal Paris, a division of L'Oreal USA, Inc. is a total beauty care company that combines the latest in technol
'/>"/>

SOURCE L'Oreal Paris
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Comparison between warfarin and aspirin
2. Clinical Comparisons Between ADHD Drugs Are Less
3. Differences in brain pattern among liars and cheats in comparison to honest people
4. Disney in Trouble? Negative Excitement in Disneyland, Paris
5. Primary Health Care Parishioners of Second Largest HIV Infected Area in US Fail to Offer HIV Tests
6. Bistronomy is Conquering Dining in Paris
7. 45 Day Jail Sentence for Paris Hilton
8. Paris is Out of the Medical Ward and Back in the Slammer
9. Paris Sex Tape Comes Back to Haunt Her in the Slammer
10. Paris medical Condition is a Sexually Transmitted Infection
11. Paris Hilton Turns to the Virgin Mary to Save Her from the Slammer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...s supporting the US Department of Defense and Fede...n Phoenix. Operation Golden Phoenix is a, four-d...gned to assist, federal, state and local agencies ...ios. Dataline is providing a vital, ad-hoc, secure...l use during the exercise., NORFOLK, Va., July 25...
(Date:7/25/2008)...Relationship Based on Significant Improvements in ... MDdatacor, Inc., a leader in health,care quality ...s, today,announced it has entered into a long-term...ort Wellmark,s Collaboration on Quality(SM) Incent...tion between Wellmark and,primary care clinicians ...
(Date:7/25/2008)...BURG, Ill., July 25 /PRNewswire/ -- Sagent Pharmac...eutical company, today announced that it,has launc...iarrhythmic,indicated for the treatment and prophy...tion and hemodynamically unstable ventricular,tach...r heart beat.,Sagent,s amiodarone HCl injection wi...
(Date:7/25/2008)...to benefit ALS Therapy Alliance to be presented at...t, WOONSOCKET, R.I., July 25 /PRNewswire/ -- CVS/...sed a record-breaking $4.4 million in just 21 days...for ALS research. This is,the seventh year of the ...ed more than $15 million for ALS research. This ye...
Breaking Medicine News(10 mins):Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2
... in the British Medical Journal, researchers at Ox...e as 2 per cent in the consumption of common foods...er cent increase in coronary heart disease. Trans...ure and shelf life of food and is added to most fa...
...rams help to reduce sexual activities among young ...hout interfering in future condom use, according//...tion strategy.The study was conducted on 662 Afric...ity middle schools in Philadelphia and it was foun...
... prevention of discrimination against HIV/AIDS vic...efore the Cabinet for approval.// In the light of...th Minister Anbumani Ramadoss said, "it took a lit...nts to the draft and elaborate discussions with th...
...ay be more appropriate in men with low-risk prosta...surgery or radiation therapy, according to a resea...bor. The results of the study conducted by lead r...ciates have been published in the Journal of the N...
Other Medicine News:Health News:HIV Prevention through Abstinence-only Programs 2Health News:Legislation to Prevent Discrimination against HIV/AIDS Victims 2Health News:Watchful Waiting Effective for Low Risk Prostate Cancer 2
(Date:7/23/2008)...ASPS Study Finds Some Areas of the Body Have Great...S, Ill., July 23 /PRNewswire-USNewswire/ -- Fat re...gh liposuction was found to be,an excellent source...ns,than other areas of the body, reports a Brazili...ive Surgery(R), the official medical journal of th...
(Date:7/22/2008)...BRISBANE, Australia, July 22 /PRNewswire-FirstCall...te yesterday, the Board of Progen,Pharmaceuticals ...hat it,had discontinued the PI-88 phase 3 study in...ction to develop its existing portfolio of compoun...dditional compounds and,opportunities through Merg...
(Date:7/22/2008)... FDA Meeting to Discuss Development Plan Complet...wire-FirstCall/ -- Amarin Corporation,plc (NASDAQ:... met with,officials at the U.S. Food and Drug Admi... develop AMR101 for the treatment of,hypertriglyce...is,proceeding to Phase 3 with AMR101 in hypertrigl...
(Date:7/22/2008)...EO Geoffrey Allan Will Stress the Importance to Pa...logics Approval Pathway, RICHMOND, Va., July 22 /...NSM) a developer of follow-on biologics and biopha... Ph.D., CEO of Insmed, will present at a,Congressi...s the,significant need for establishing an approva...
Breaking Medicine Technology:Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3FDA Advisory Committee Unanimously Recommends U S Approval of Sugammadex the First and Only Selective Relaxant Binding Agent 1504 1FDA Advisory Committee Unanimously Recommends U S Approval of Sugammadex the First and Only Selective Relaxant Binding Agent 1504 2FDA Advisory Committee Unanimously Recommends U S Approval of Sugammadex the First and Only Selective Relaxant Binding Agent 1504 3FDA Advisory Committee Unanimously Recommends U S Approval of Sugammadex the First and Only Selective Relaxant Binding Agent 1504 4WellPoint Announces Appearances at Upcoming Conferences 14092 1WellPoint Announces Appearances at Upcoming Conferences 14092 2Robbins 26 Myers Schedules Second Quarter Fiscal 2008 Financial Results Conference Call 14090 1Post Op Chemo Fails to Boost Survival in Stomach Cancers 14089 1Post Op Chemo Fails to Boost Survival in Stomach Cancers 14089 2
...ical Professional Diagnostics is a leading provide...IFA and DFA test menu that includes kits for autoi...ll as miscellaneous conjugates and components. Our...t of substrates and kit sizes to choose from. Kit ...
...ical Professional Diagnostics is a leading provide...IFA and DFA test menu that includes kits for autoi...ll as miscellaneous conjugates and components. Our...t of substrates and kit sizes to choose from. Kit ...
...ical Professional Diagnostics is a leading provide...IFA and DFA test menu that includes kits for autoi...ll as miscellaneous conjugates and components. Our...t of substrates and kit sizes to choose from. Kit ...
...ical Professional Diagnostics is a leading provide...IFA and DFA test menu that includes kits for autoi...ll as miscellaneous conjugates and components. Our...t of substrates and kit sizes to choose from. Kit ...
Medicine Products: